| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS INC | Director | Common Stock | 171,444 | $690,919 | $4.03 | 05 Jun 2025 | Direct |
| Talis Biomedical Corp | Director | Stock option (right to buy) | 5,466 | 09 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:05 |
| MYGN | MYRIAD GENETICS INC | 09 Sep 2024 | 1 | -$270,520 | 4 | Director | 09 Sep 2024, 17:48 |
| MYGN | MYRIAD GENETICS INC | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:54 |
| /report/000120919123036374-dreismann-heinrich-2023-06-09 | Talis Biomedical Corp | 09 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 17:13 |
| MYGN | MYRIAD GENETICS INC | 01 Jun 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 18:05 |
| /report/000120919123031639-dreismann-heinrich-2023-05-19 | Talis Biomedical Corp | 19 May 2023 | 1 | $0 | 4 | Director | 23 May 2023, 08:33 |
| /report/000120919123031637-dreismann-heinrich-2023-05-19 | Talis Biomedical Corp | 19 May 2023 | 0 | $0 | 3 | Director | 23 May 2023, 08:32 |
| MYGN | MYRIAD GENETICS INC | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 17:25 |